We are live on
!
Find out more
KeyBank National Association Portfolio holdings
AUM
$30.4B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+7.78%
1 Year Est. Return
+27.51%
3 Year Est. Return
+84.1%
5 Year Est. Return
+102.71%
10 Year Est. Return
+303.78%
AUM
$18.7B
AUM Growth
+$1.12B
(+6.4%)
Cap. Flow
-$139M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
32.57%
Holding
1,048
New
67
Increased
311
Reduced
534
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$64.8M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$31.4M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$11.6M |
| 4 |
NVIDIA
NVDA
|
+$10.4M |
| 5 |
Parker-Hannifin
PH
|
+$9.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$19.7M |
| 2 |
CELG
Celgene Corp
CELG
|
+$19.1M |
| 3 |
K
Kellanova
K
|
+$13.2M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$12.3M |
| 5 |
Abbott
ABT
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 13.77% |
| 2 | Technology | 11.94% |
| 3 | Healthcare | 7.91% |
| 4 | Financials | 7.77% |
| 5 | Industrials | 6.98% |
Similar funds
KeyBank National Association's Q4 2019 Portfolio in Review
As of Q4 2019, KeyBank National Association held 1,048 positions worth $18.7B, up 6.4% from $17.5B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
KeyBank National Association's Q4 2019 filing shows 67 new, 311 increased, 534 reduced and 52 closed positions. Its largest new stake was Invesco Preferred ETF: 224,199 shares worth $3.37M. The largest sale was Pfizer, an estimated $19.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- KeyBank National Association's largest Q4 2019 buy was Invesco Preferred ETF: 224,199 shares worth $3.37M.
- KeyBank National Association added most to iShares MSCI USA Min Vol Factor ETF in Q4 2019, an estimated $64.8M increase.
- KeyBank National Association's biggest Q4 2019 reduction was Pfizer, cutting an estimated $19.7M.
- KeyBank National Association fully exited Celgene Corp in Q4 2019, selling an estimated $19.1M.
- KeyBank National Association's ten largest holdings make up 33% of its $18.7B portfolio in Q4 2019.
- KeyBank National Association opened 67 new positions and closed 52 in Q4 2019.
- KeyBank National Association's portfolio value rose 6.4% quarter-over-quarter to $18.7B.
Based on KeyBank National Association's 13F filing for Q4 2019, filed 5 Feb 2020.